352
Views
16
CrossRef citations to date
0
Altmetric
Research Article

Therapeutic potential of Chromolaena odorata phyto-constituents against human pancreatic α-amylase

ORCID Icon, , &
Pages 1801-1812 | Received 08 Jun 2020, Accepted 02 Oct 2020, Published online: 15 Oct 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Babatomiwa Kikiowo, Iqrar Ahmad, Adebowale A. Alade, Taiwo T. Ijatuyi, Opeyemi Iwaloye & Harun M. Patel. (2023) Molecular dynamics simulation and pharmacokinetics studies of ombuin and quercetin against human pancreatic α-amylase. Journal of Biomolecular Structure and Dynamics 41:20, pages 10388-10395.
Read now
Weiwei Xu, Rui Peng, Siyu Chen, Congcong Wu, Xiaoxiao Wang, Ting Yu, Jiuying Jian, Ni Zhang, Siyang Zuo, Min Chen, Bing Guo & Lirong Liu. (2022) Ranunculus ternatus Thunb extract attenuates renal fibrosis of diabetic nephropathy via inhibiting SMYD2. Pharmaceutical Biology 60:1, pages 300-307.
Read now
Doudou Huang, Zenan Du, Yanhong Chen, Zhiying Dong, Xiujuan Wang, Mengshuang Li, Feng Zhang, Wansheng Chen & Lianna Sun. (2021) Bio-Guided Isolation of Two New Hypoglycemic Triterpenoid Saponins from Polygonum capitatum. Drug Design, Development and Therapy 15, pages 5001-5010.
Read now

Articles from other publishers (13)

Ngoc-Dung Huynh Luu, Le Hang Dang, Tuong-Van Vo Le, Thuy-Duong Ngoc Do, Thanh-Tuyen Thi Nguyen, Trang Thuy Thi Nguyen, Thi Phuong Nguyen, Le Son Hoang & Ngoc Quyen Tran. (2023) Topical cream based on nanoformulation of Chromolaena odorata extract for accelerating burn wound healing. Journal of Drug Delivery Science and Technology 82, pages 104360.
Crossref
Opeyemi Iwaloye, Olusola Olalekan Elekofehinti, Femi Olawale, Prosper Obed Chukwuemeka, Babatomiwa Kikiowo & Ibukun Mary Folorunso. (2023) Fragment-Based Drug Design, 2D-QSAR and DFT Calculation: Scaffolds of 1, 2, 4, triazolo [1, 5-a] pyrimidin-7-amines as Potential Inhibitors of Plasmodium falciparum Dihydroorotate Dehydrogenase. Letters in Drug Design & Discovery 20:3, pages 317-334.
Crossref
Olusola Olusola Elekofehinti. (2023) Computer-aided identification of bioactive compounds from Gongronema latifolium leaf with therapeutic potential against GSK3β, PTB1B and SGLT2. Informatics in Medicine Unlocked 38, pages 101202.
Crossref
EL Hassania Loukili, Btissam Bouchal, Mohamed Bouhrim, Farid Abrigach, Manon Genva, Kahina Zidi, Mohamed Bnouham, Mohammed Bellaoui, Belkheir Hammouti, Mohamed Addi, Mohammed Ramdani & Marie-Laure Fauconnier. (2022) Chemical Composition, Antibacterial, Antifungal and Antidiabetic Activities of Ethanolic Extracts of Opuntia dillenii Fruits Collected from Morocco. Journal of Food Quality 2022, pages 1-15.
Crossref
Mohammed Dalli, Nour Elhouda Daoudi, Farid Abrigach, Salah-eddine Azizi, Mohamed Bnouham, Bonglee Kim & Nadia Gseyra. (2022) In vitro α-amylase and hemoglobin glycation inhibitory potential of Nigella sativa essential oil, and molecular docking studies of its principal components. Frontiers in Pharmacology 13.
Crossref
Bin Liu, Caichun Deng & Ping Tan. (2022) Ombuin ameliorates diabetic nephropathy in rats by anti‐inflammation and antifibrosis involving Notch 1 and PPAR γ signaling pathways. Drug Development Research 83:6, pages 1270-1280.
Crossref
Titilayo Omolara Johnson, Abayomi Emmanuel Adegboyega, Oluwafemi Adeleke Ojo, Amina Jega Yusuf, Opeyemi Iwaloye, Chinenye Jane Ugwah-Oguejiofor, Rita Onyekachukwu Asomadu, Ifeoma Felicia Chukwuma, Stephen Adakole Ejembi, Emmanuel Ike Ugwuja, Saqer S. Alotaibi, Sarah M. Albogami, Gaber El-Saber Batiha, Bodour S. Rajab & Carlos Adam Conte-Junior. (2022) A Computational Approach to Elucidate the Interactions of Chemicals From Artemisia annua Targeted Toward SARS-CoV-2 Main Protease Inhibition for COVID-19 Treatment. Frontiers in Medicine 9.
Crossref
Femi Olawale, Kolawole Olofinsan & Opeyemi Iwaloye. (2022) Biological activities of Chromolaena odorata: A mechanistic review. South African Journal of Botany 144, pages 44-57.
Crossref
Basiru Olaitan Ajiboye, Opeyemi Iwaloye, Olutunmise Victoria Owolabi, Jerius Nkwuda Ejeje, Alice Okerewa, Oluwafolakemi O. Johnson, Ashley Eguonor Udebor & Babatunji Emmanuel Oyinloye. (2021) Screening of potential antidiabetic phytochemicals from Gongronema latifolium leaf against therapeutic targets of type 2 diabetes mellitus: multi-targets drug design. SN Applied Sciences 4:1.
Crossref
Olusola Olalekan Elekofehinti, Nicholas Adeyemi Adewumi & Opeyemi Iwaloye. (2021) Antidiabetic potential of Chromolaena Odorata leave extract and its effect on Nrf2/keap1 antioxidant pathway in the liver of diabetic-induced Wistar Rats. Advances in Traditional Medicine.
Crossref
Olusola Olalekan Elekofehinti, Opeyemi Iwaloye, Femi Olawale, Prosper Obed Chukwuemeka & Ibukun Mary Folorunso. (2021) Newly designed compounds from scaffolds of known actives as inhibitors of survivin: computational analysis from the perspective of fragment-based drug design. In Silico Pharmacology 9:1.
Crossref
Babatunji Emmanuel Oyinloye, Opeyemi Iwaloye & Basiru Olaitan Ajiboye. (2021) Polypharmacology of Gongronema latifolium leaf secondary metabolites against protein kinases implicated in Parkinson's disease and Alzheimer's disease. Scientific African 12, pages e00826.
Crossref
Victor Okoliko Ukwenya, Sunday Aderemi Adelakun & Olusola Olalekan Elekofehinti. (2021) Exploring the antidiabetic potential of compounds isolated from Anacardium occidentale using computational aproach: ligand-based virtual screening. In Silico Pharmacology 9:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.